Silvercrest Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.43M Sell
20,338
-100
-0.5% -$27.1K 0.04% 411
2025
Q4
$5.13M Hold
20,438
0.04% 431
2025
Q3
$5.87M Sell
20,438
-33
-0.2% -$8.84K 0.04% 408
2025
Q2
$5.37M Buy
20,471
+52
+0.3% +$12.7K 0.04% 423
2025
Q1
$4.75M Sell
20,419
-2,862
-12% -$695K 0.03% 412
2024
Q4
$5.34M Sell
23,281
-215
-0.9% -$49.3K 0.04% 412
2024
Q3
$5.25M Sell
23,496
-35
-0.1% -$7.69K 0.04% 379
2024
Q2
$4.79M Buy
23,531
+42
+0.2% +$8.54K 0.03% 406
2024
Q1
$5.13M Sell
23,489
-1,867
-7% -$411K 0.03% 387
2023
Q4
$5.76M Sell
25,356
-666
-3% -$140K 0.04% 351
2023
Q3
$5.23M Sell
26,022
-5,703
-18% -$1.2M 0.04% 353
2023
Q2
$6.58M Buy
31,725
+398
+1% +$77.2K 0.05% 317
2023
Q1
$6.17M Sell
31,327
-26,666
-46% -$5.49M 0.05% 305
2022
Q4
$11.7M Sell
57,993
-179,138
-76% -$35M 0.09% 202
2022
Q3
$41.7M Sell
237,131
-7,122
-3% -$1.46M 0.34% 103
2022
Q2
$49.2M Buy
244,253
+2,134
+0.9% +$455K 0.37% 95
2022
Q1
$54.8M Sell
242,119
-72,808
-23% -$17.1M 0.36% 95
2021
Q4
$85M Sell
314,927
-398
-0.1% -$98.5K 0.54% 59
2021
Q3
$76.2M Sell
315,325
-5,747
-2% -$1.45M 0.51% 65
2021
Q2
$76.1M Sell
321,072
-210,437
-40% -$47.9M 0.5% 69
2021
Q1
$116M Buy
531,509
+15,820
+3% +$3.17M 0.79% 20
2020
Q4
$90.2M Buy
515,689
+20,238
+4% +$3.5M 0.66% 42
2020
Q3
$80.1M Sell
495,451
-5,777
-1% -$916K 0.69% 39
2020
Q2
$71.5M Sell
501,228
-11,386
-2% -$1.58M 0.63% 51
2020
Q1
$55.7M Sell
512,614
-18,146
-3% -$2.61M 0.6% 61
2019
Q4
$77.1M Sell
530,760
-1,700
-0.3% -$245K 0.6% 56
2019
Q3
$76.8M Buy
532,460
+2,897
+0.5% +$423K 0.63% 52
2019
Q2
$78.7M Buy
529,563
+34,238
+7% +$4.78M 0.74% 44
2019
Q1
$65.1M Buy
495,325
+2,486
+0.5% +$306K 0.64% 58
2018
Q4
$53.5M Sell
492,839
-14,364
-3% -$1.92M 0.59% 65
2018
Q3
$75.7M Buy
507,203
+9,030
+2% +$1.37M 0.69% 45
2018
Q2
$76.8M Sell
498,173
-36,713
-7% -$5.54M 0.72% 41
2018
Q1
$74.3M Sell
534,886
-6,933
-1% -$1.02M 0.72% 43
2017
Q4
$74.2M Sell
541,819
-830
-0.2% -$110K 0.69% 49
2017
Q3
$70.4M Sell
542,649
-3,395
-0.6% -$453K 0.7% 49
2017
Q2
$72.3M Buy
546,044
+3,605
+0.7% +$441K 0.77% 45
2017
Q1
$66.9M Buy
542,439
+25,568
+5% +$3.03M 0.72% 49
2016
Q4
$57M Buy
516,871
+34,750
+7% +$3.86M 0.64% 60
2016
Q3
$56.9M Buy
482,121
+20,510
+4% +$2.42M 0.68% 52
2016
Q2
$51.7M Buy
+461,611
New +$49.7M 0.66% 57

Other funds holding LH

Silvercrest Asset Management's LH Position: Q1 2026 in Review

Silvercrest Asset Management reduced its Labcorp (LH) stake by 0.49% in Q1 2026, selling an estimated $27.1K and leaving 20,338 shares worth $5.43M. The position accounts for 0.04% of the portfolio, ranked #411.

Silvercrest Asset Management first reported a position in LH in Q2 2016 and has held it in 40 quarters since. The position peaked at $116M in Q1 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Silvercrest Asset Management held 20,338 shares of Labcorp worth $5.43M as of Q1 2026.
  • Silvercrest Asset Management sold 100 Labcorp shares in Q1 2026, an estimated $27.1K.
  • Labcorp made up 0.04% of Silvercrest Asset Management's portfolio in Q1 2026, its #411 holding.
  • Silvercrest Asset Management first reported a position in Labcorp in Q2 2016 and has held it in 40 quarters since.
  • Silvercrest Asset Management's Labcorp position peaked at $116M in Q1 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.